These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12771309

  • 1. Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats.
    Nagano N, Miyata S, Obana S, Kobayashi N, Abe M, Fukushima N, Wada M.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii81-5. PubMed ID: 12771309
    [Abstract] [Full Text] [Related]

  • 2. Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency.
    Nagano N, Miyata S, Obana S, Ozai M, Kobayashi N, Fukushima N, Burke SK, Wada M.
    Nephrol Dial Transplant; 2001 Sep; 16(9):1870-8. PubMed ID: 11522872
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
    Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E.
    J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
    Xiao X, Liu Y, Zhong X, Liu Y, Zhou D, Xiong X, Ran J.
    Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442
    [Abstract] [Full Text] [Related]

  • 8. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
    Nagano N, Miyata S, Obana S, Kobayashi N, Fukushima N, Burke SK, Wada M.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2014-23. PubMed ID: 13679475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.
    Chertow GM, Dillon MA, Amin N, Burke SK.
    J Ren Nutr; 2000 Jul; 10(3):125-32. PubMed ID: 10921533
    [Abstract] [Full Text] [Related]

  • 11. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Nagano N, Miyata S, Abe M, Wakita S, Kobayashi N, Wada M.
    Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
    [Abstract] [Full Text] [Related]

  • 12. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.
    Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ.
    J Clin Invest; 1996 Jun 01; 97(11):2534-40. PubMed ID: 8647946
    [Abstract] [Full Text] [Related]

  • 13. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
    Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K.
    Nephron; 1995 Jun 01; 70(2):242-8. PubMed ID: 7566311
    [Abstract] [Full Text] [Related]

  • 14. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Jun 01; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
    Ando R, Naito S, Inagaki Y, Hata T, Ishida Y, Chida Y, Takayama M, Tachibana K, Ohtsuka M, Inoue A.
    Ther Apher Dial; 2005 Feb 01; 9(1):16-23. PubMed ID: 15828901
    [Abstract] [Full Text] [Related]

  • 18. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.
    Brown AJ, Ritter CS, Finch JL, Slatopolsky EA.
    Kidney Int; 1999 Apr 01; 55(4):1284-92. PubMed ID: 10200992
    [Abstract] [Full Text] [Related]

  • 19. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S, Zhang W, Mao J, Wang M, Ni L, Zhang M, Zhang Q, Chen J.
    J Nephrol; 2018 Dec 01; 31(6):941-951. PubMed ID: 30171599
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
    Naveh-Many T, Rahamimov R, Livni N, Silver J.
    J Clin Invest; 1995 Oct 01; 96(4):1786-93. PubMed ID: 7560070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.